PIT, that is actually a concern I have expressed on the CYDY board. The significant improvement in the standard of care in reducing mortality, has got to result in showing further statistical significance in mortality reduction very difficult, and that is their primary endpoint. I would think they would need to increase their trial size, perhaps dramatically, to show success. But it would be fantastic if they can meet their endpoint without adding patients.
News 
Market Data 
Discover 
AI
